Lynch Thomas G 4
4 · Evofem Biosciences, Inc. · Filed Aug 2, 2018
Insider Transaction Report
Form 4
Lynch Thomas G
Director
Transactions
- Award
Stock option (right to buy)
2018-07-31+0→ 85,500 totalExercise: $2.10Exp: 2028-07-31→ Common Stock (85,500 underlying)
Footnotes (1)
- [F1]The shares of common stock exercisable pursuant to the option will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from July 31, 2018. The option was awarded in connection with Mr. Lynch's consulting services.